-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Suspends Neutral Rating on Theravance Biopharma

Benzinga·09/24/2026 09:27:01
BTIG suspends Neutral rating on Theravance Biopharma (NASDAQ:TBPH).